Literature DB >> 29657943

The Relationship between Tuberculosis and Lung Cancer.

Masoud Keikha1, Bahram Nasr Esfahani1.   

Abstract

Entities:  

Year:  2018        PMID: 29657943      PMCID: PMC5887688          DOI: 10.4103/abr.abr_182_17

Source DB:  PubMed          Journal:  Adv Biomed Res        ISSN: 2277-9175


× No keyword cloud information.
Sir, Lung cancer has been recognized as one of the greatest common cancers, causing the annual mortality rate of about 1.2 million people in the world. Lung cancer is the most prevalent cancer in men and the third-most common cancer among women (after breast and digestive cancers).[1] Recent evidences have shown the inflammatory process as one of the potential factors of cancer. Tuberculosis (TB), pneumonia, and chronic bronchitis are among the most important inflammation-inducing factors in the lungs, among which TB has a more profound role in the emergence of cancer.[2] TB is one of the important mortality factors throughout the world, and 205,000 death cases are reported annually due to this disease.[3] Chronic inflammation and fibrosis due to TB can induce genetic mutation and alternations. Parenchyma tissue of lung is involved in both diseases of TB and lung cancer, and continuous cough in lung cancer, morphological vascular variations, lymphocytosis processes, and generation of immune system mediators such as interleukins, are all among the factors leading to the hypothesis regarding the role of TB in lung cancer.[12345] Some reports have shown that the induction of necrosis and apoptosis or TB reactivation, especially in patients with immune-deficiency, may result in increasing IL-17 and TNF_α, which will either decrease P53 activity or increase the expression of Bcl-2, decrease Bax-T, and cause the inhibition of caspase-3 expression due to decreasing the expression of mitochondria cytochrome oxidase.[67] It has been also indicated that following the injection of BCG vaccine, the host immune system will be reinforced and in particular, the rates of gamma interferon, nitric oxide, and interleukin-2 are increased. Therefore, CD4 + lymphocyte function will be improved and the person will be immune against cancer.[8] Numerous prospective studies have so far been conducted on the role of TB in lung cancer, and it seems that this disease is effective in that particular cancer.[123910] One of the main challenges of lung cancer is its correct and timely diagnosis. Unfortunately, clinical symptoms (such as continuous cough, hemoptysis, weight loss, fever, chest pain, dyspnea, and loss of appetite) and radiological images are similar in TB and lung cancer.[59] Therefore, anti-TB drugs are routinely prescribed for the patients in the countries with high prevalence of TB, like Iran. Regarding the similarity in clinical symptoms and radiological findings of lung cancer, proper diagnosis is necessary for TB and respiratory infections due to nontuberculous mycobacteria (NTM). Some of the drug resistive TB cases are in fact lung cancer or NTM lung infections. Acid-fast staining and histological study of phlegm and bronchial washing, culturing and polymerase chain reaction TB are among the most important solutions for differential diagnosis of these diseases.[511] Briefly, it is assumed that TB is one of the risk factors for cancer. Numerous studies have been conducted in this regard throughout the world and it has been observed that there is a significant relationship between previous TB infection and lung cancer. However, to prove this hypothesis, further and more extensive studies are required. In addition, as the clinical symptoms and radiological findings of TB, lung cancer, and non-TB mycobacteria lung infections are similar, they can be misdiagnosed as TB. For proper and timely treatments, the required diagnosis should be correct and properly done.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

1.  Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.

Authors:  Giovanna Liuzzo; Francesco Trotta; Daniela Pedicino
Journal:  Eur Heart J       Date:  2012-11-23       Impact factor: 29.983

2.  Tuberculosis and lung cancer. An interesting case study.

Authors:  F Mariani; M Bocchino; G Cappelli; T Persechini; V Colizzi; E Bonanno; A Ponticiello; A Sanduzzi
Journal:  Monaldi Arch Chest Dis       Date:  2001-02

3.  Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study.

Authors:  Chen-Yi Wu; Hsiao-Yun Hu; Cheng-Yun Pu; Nicole Huang; Hsi-Che Shen; Chung-Pin Li; Yiing-Jeng Chou
Journal:  Cancer       Date:  2010-09-30       Impact factor: 6.860

4.  Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.

Authors:  Eric A Engels; Min Shen; Robert S Chapman; Ruth M Pfeiffer; Ying-Ying Yu; Xingzhou He; Qing Lan
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

Review 5.  Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review.

Authors:  Hui-Ying Liang; Xue-Lian Li; Xiao-Song Yu; Peng Guan; Zhi-Hua Yin; Qin-Cheng He; Bao-Sen Zhou
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

Review 6.  Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.

Authors:  Darren R Brenner; John R McLaughlin; Rayjean J Hung
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

7.  Lung cancer in patients with tuberculosis.

Authors:  Saulius Cicenas; Vladislavas Vencevicius
Journal:  World J Surg Oncol       Date:  2007-02-19       Impact factor: 2.754

8.  Lung cancer and prior tuberculosis infection in Shanghai.

Authors:  W Zheng; W J Blot; M L Liao; Z X Wang; L I Levin; J J Zhao; J F Fraumeni; Y T Gao
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

Review 9.  Prevalence of Non-Tuberculosis Mycobacterial Infections among Tuberculosis Suspects in Iran: Systematic Review and Meta-Analysis.

Authors:  Mohammad Javad Nasiri; Hossein Dabiri; Davood Darban-Sarokhalil; Abdolrazagh Hashemi Shahraki
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Pulmonary tuberculosis as differential diagnosis of lung cancer.

Authors:  Mlb Bhatt; Surya Kant; Ravi Bhaskar
Journal:  South Asian J Cancer       Date:  2012-07
View more
  11 in total

1.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

2.  Attitudes toward tobacco cessation and lung cancer screening in two South African communities.

Authors:  Grace C Hillyer; Witness Mapanga; Judith S Jacobson; Anita Graham; Keletso Mmoledi; Raynolda Makhutle; Daniel Osei-Fofie; Mubenga Mulowayi; Brenda Masuabi; William A Bulman; Alfred I Neugut; Maureen Joffe
Journal:  Glob Public Health       Date:  2020-05-14

3.  Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1/PDl-1 signaling pathway.

Authors:  Shuhui Cao; Jingwen Li; Jun Lu; Runbo Zhong; Hua Zhong
Journal:  Cell Death Dis       Date:  2019-01-18       Impact factor: 8.469

4.  Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment.

Authors:  Syed Sarim Imam; Sultan Alshehri; Mohammad A Altamimi; Afzal Hussain; Khaled Hamad Alyahya; Wael A Mahdi; Wajhul Qamar
Journal:  ACS Omega       Date:  2021-12-23

Review 5.  Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer.

Authors:  Afsana Sheikh; Nabil A Alhakamy; Shadab Md; Prashant Kesharwani
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

6.  An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.

Authors:  Aftab Alam; Hala Abubaker Bagabir; Armiya Sultan; Mohd Faizan Siddiqui; Nikhat Imam; Mustfa F Alkhanani; Ahmad Alsulimani; Shafiul Haque; Romana Ishrat
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 7.  Pulmonary Tuberculosis and Risk of Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Soo Young Hwang; Jong Yeob Kim; Hye Sun Lee; Sujee Lee; Dayeong Kim; Subin Kim; Jong Hoon Hyun; Jae Il Shin; Kyoung Hwa Lee; Sang Hoon Han; Young Goo Song
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

Review 8.  The first report of co-existence of pulmonary tuberculosis and lung malignancy in a kidney transplant recipient: a case report and literature review.

Authors:  Gang Fang; Ning-Chang Cheng; Li-Li Huang; Wei-Ping Xie; Chun-Mei Hu; Wei Chen
Journal:  BMC Infect Dis       Date:  2021-07-01       Impact factor: 3.090

9.  The Role of Chest CT Radiomics in Diagnosis of Lung Cancer or Tuberculosis: A Pilot Study.

Authors:  Lekshmi Thattaamuriyil Padmakumari; Gisella Guido; Damiano Caruso; Ilaria Nacci; Antonella Del Gaudio; Marta Zerunian; Michela Polici; Renuka Gopalakrishnan; Aziz Kallikunnel Sayed Mohamed; Domenico De Santis; Andrea Laghi; Dania Cioni; Emanuele Neri
Journal:  Diagnostics (Basel)       Date:  2022-03-18

10.  [A Rare Case of Non-small Cell Lung Carcinoma Squamous Phenotype with Epstein-Barr Virus Positivity with Prolonged Response to both Chemotherapy and Radiotherapy].

Authors:  Carolina Navarro Rodriguez; Muhammad Shahid Iqbal; Max Robinson; Graham Burns; Alastair Greystoke
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.